These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 18198394)

  • 1. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial.
    Bolland MJ; Barber PA; Doughty RN; Mason B; Horne A; Ames R; Gamble GD; Grey A; Reid IR
    BMJ; 2008 Feb; 336(7638):262-6. PubMed ID: 18198394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.
    Bolland MJ; Avenell A; Baron JA; Grey A; MacLennan GS; Gamble GD; Reid IR
    BMJ; 2010 Jul; 341():c3691. PubMed ID: 20671013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.
    Bolland MJ; Grey A; Avenell A; Gamble GD; Reid IR
    BMJ; 2011 Apr; 342():d2040. PubMed ID: 21505219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium intake on the cardiovascular system in postmenopausal women.
    Challoumas D; Cobbold C; Dimitrakakis G
    Atherosclerosis; 2013 Nov; 231(1):1-7. PubMed ID: 24125401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does widespread calcium supplementation pose cardiovascular risk? No: concerns are unwarranted.
    Bhattacharya RK
    Am Fam Physician; 2013 Feb; 87(3):Online. PubMed ID: 23418771
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium supplementation: Some issues on outcomes.
    Ramlackhansingh JN
    BMJ; 2008 Feb; 336(7641):403; author reply 404. PubMed ID: 18292135
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium supplementation and vascular disease.
    Reid IR; Bolland MJ
    Climacteric; 2008 Aug; 11(4):280-6. PubMed ID: 18645693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium supplementation: balancing the cardiovascular risks.
    Reid IR; Bolland MJ; Sambrook PN; Grey A
    Maturitas; 2011 Aug; 69(4):289-95. PubMed ID: 21621353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium supplementation: cardiovascular risk?
    Prescrire Int; 2013 Jun; 22(139):152-3. PubMed ID: 23866352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium supplementation, cardiovascular disease and mortality in older women.
    Shah SM; Carey IM; Harris T; DeWilde S; Cook DG
    Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):59-64. PubMed ID: 19757413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials.
    Lewis JR; Radavelli-Bagatini S; Rejnmark L; Chen JS; Simpson JM; Lappe JM; Mosekilde L; Prentice RL; Prince RL
    J Bone Miner Res; 2015 Jan; 30(1):165-75. PubMed ID: 25042841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does widespread calcium supplementation pose cardiovascular risk? Yes: the potential risk is a concern.
    Reid IR; Bolland MJ
    Am Fam Physician; 2013 Feb; 87(3):Online. PubMed ID: 23418770
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium and vitamin D for increasing bone mineral density in premenopausal women.
    Méndez-Sánchez L; Clark P; Winzenberg TM; Tugwell P; Correa-Burrows P; Costello R
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012664. PubMed ID: 36705288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.
    Galan P; Kesse-Guyot E; Czernichow S; Briancon S; Blacher J; Hercberg S;
    BMJ; 2010 Nov; 341():c6273. PubMed ID: 21115589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
    Schierbeck LL; Rejnmark L; Tofteng CL; Stilgren L; Eiken P; Mosekilde L; Køber L; Jensen JE
    BMJ; 2012 Oct; 345():e6409. PubMed ID: 23048011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease.
    Jiang X; Nudy M; Aragaki AK; Robbins JA; Manson JE; Stefanick ML; OʼSullivan DM; Shikany JM; LeBlanc ES; Kelsey AM; Cauley J; Martin LW; Payne ME; Johnson KC; Howard B; Schnatz PF
    Menopause; 2019 Aug; 26(8):841-849. PubMed ID: 31145202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial.
    Bolland MJ; Barber A; Doughty RN; Grey A; Gamble G; Reid IR
    BMJ Open; 2013 Mar; 3(3):. PubMed ID: 23512838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.